Clinical Trial Update: Safety and Effectiveness Study of Chemotherapy in Combination With Erlotinib,or Sequential Erlotinib for Treatment in Patients With NSCLC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and effectiveness of chemotherapy in combination with erlotinib, or sequential erlotinib, for non-small cell lung c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Tarceva (erlotinib)

Snippet

Sponsor: Fudan University | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN